Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:11-HDoHE)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003788 AN006227 Pre-treatment untargeted cerebrospinal fluid metabolomic profiling in tuberculous meningitis reveals multiple pathways associated with mortality Cerebrospinal fluid Human Meningitis Broad Institute of MIT and Harvard LC-MS
ST003788 AN006227 Pre-treatment untargeted cerebrospinal fluid metabolomic profiling in tuberculous meningitis reveals multiple pathways associated with mortality Cerebrospinal fluid Human Tuberculosis Broad Institute of MIT and Harvard LC-MS
ST003049 AN005000 Plasma instead of serum avoids critical confounding of clinical metabolomics studies by platelets Blood Human University of Vienna LC-MS
ST002823 AN004604 Smoking Induced Gut Microbial Dysbiosis Mediates Cancer Progression Through Adaptive Immune System Modulation Feces Mouse Cancer University of Alabama, Birmingham LC-MS
ST002471 AN004036 Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human stool profiling Feces Human Ulcerative colitis Broad Institute of MIT and Harvard LC-MS
ST002470 AN004032 Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human plasma profiling Blood Human Ulcerative colitis Broad Institute of MIT and Harvard LC-MS
ST002455 AN004005 Organism-Wide Analysis of Sepsis Reveals Mechanisms of Systemic Inflammation Blood Mouse Sepsis University of Chicago LC-MS
ST002354 AN003843 Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. Blood Rat Cancer UConn Health LC-MS
ST002354 AN003843 Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. Colon Rat Cancer UConn Health LC-MS
ST002354 AN003845 Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. Blood Rat Cancer UConn Health LC-MS
ST002354 AN003845 Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. Colon Rat Cancer UConn Health LC-MS
ST002247 AN003673 Microbiota and Health Study (Dhaka, Bangladesh) Feces Human Broad Institute of MIT and Harvard LC-MS
ST002246 AN003669 Longitudinal fecal metabolomic profiles from mothers and their infants in the EDIA study Feces Human Broad Institute of MIT and Harvard LC-MS
ST001951 AN003176 Quantification of ω-3 fatty acids and their derivatives in lungs from hypoxia-induced pulmonary hypertension (PH) mice. Lung Mouse Pulmonary hypertension University of Tokyo LC-MS
ST001215 AN002026 Effect of Mirabegron Treatment on serum lipidome Blood Human Joslin Diabetes Center LC-MS
ST001214 AN002025 Lipidommics in the serum of human subjects Blood Human Joslin Diabetes Center LC-MS
ST001213 AN002024 Serum lipidomic profile of cold-exposed Ucp1cre/12-LOX KO mice Blood Mouse Joslin Diabetes Center LC-MS
ST001207 AN002009 Lipidomics in the serum of cold exposed mice treated with 12-LOX inhibitor LOXBlock-1 Blood Mouse Joslin Diabetes Center LC-MS
ST001206 AN002008 Effects of cold exposure on serum lipidomic in mice Blood Mouse Joslin Diabetes Center LC-MS
ST000916 AN001491 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma Blood Human Fatty liver disease LIPID MAPS GC-MS/LC-MS
ST000915 AN001485 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver Liver Human Fatty liver disease LIPID MAPS GC-MS/LC-MS
ST000004 AN000004 Lipidomics studies on NIDDK / NIST human plasma samples Blood Human LIPID MAPS LC-MS
  logo